logo
Share SHARE
FONT-SIZE Plus   Neg

CHMP Adopts Negative Opinion On KYNAMROTM - Quick Facts

Genzyme, a Sanofi company (SNY), and Isis Pharmaceuticals Inc. (ISIS), announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has adopted a negative opinion for its marketing authorization application for KYNAMROTM for the treatment of patients with Homozygous Familial Hypercholesterolaemia. Genzyme plans to request a re-examination of the CHMP Opinion.

An application for KYNAMRO is currently under review by the U.S. FDA.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The best companies make employees feel comfortable, safe and valued at their workplace. Corporate culture develops organically over time from the cumulative traits of the people hired by the company. It is a combination of values, goals and vision of an organization that dictates the way people work.... Starbucks will close all its 379 Teavana stores over the coming year, with the coffee giant saying that the stores have been "persistently underperforming." The move will impact about 3,300 employees. The company made the announcement while reporting its third-quarter financial results on Thursday. Wal-Mart Stores has disappointed Nintendo fans after it cancelled pre-orders for the Super Nintendo Entertainment System - Classic Edition, a standalone mini Super Nintendo with pre-loaded games. The console is slated to be launched later this fall.
comments powered by Disqus
Follow RTT